Wednesday 18 July 2018

Reuters Health Report: AstraZeneca to stockpile drugs as Brexit 'safety net'

AstraZeneca to stockpile drugs as Brexit 'safety net'

AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in preparation for potential disruption if the UK crashes out of the EU without a deal.

U.N. says global fight against AIDS is at 'precarious point'

Complacency is starting to stall the fight against the global AIDS epidemic, with the pace of progress not matching what is needed, the United Nations warned on Wednesday.

Cancer drug movie strikes nerve in China, becomes box-office hit

A low-budget Chinese movie about a leukemia patient who turns to smuggling cheaper cancer drugs from India has struck a chord with Internet users and even the country's leaders, spotlighting national anxieties about unaffordable hospital care.

Smiths Group medical unit hurt by EU medical devices regulation

Smiths Group Plc expects a 2 percent drop in full-year revenue at its medical unit, hurt by some products losing certifications under a new regulation and the loss of two contracts in the United States, it said on Wednesday.

Teen suicide risk may be lower with intense team-based therapy

(Reuters Health) - Adolescents who have harmed themselves or tried to commit suicide may be less likely to do it again when they participate in an intense therapy program focused on both individual and family treatment, a U.S. study suggests.

Screen time linked to ADHD symptoms in teens

(Reuters Health) - Teens who spend lots of time surfing the web, playing games and chatting with friends on smartphones and tablets may be more likely to develop ADHD symptoms than youth who don't, a U.S. study suggests.

Wide variation in follow-up care for women with low-risk breast cancer

(Reuters Health) - The kind of imaging U.S. women receive after treatment for non-metastatic breast cancer can vary widely, a new study finds.

Evidence to support 'breakthrough' drugs often very limited: study

(Reuters Health) - The 46 medicines given approval through 2017 as part of the U.S. Food and Drug Administration's Breakthrough Therapy program have often been sent to patients without a large double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis by researchers at Yale University and the Yale School of Medicine.

China heart drug sold globally may have had impurity since 2012

A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday.

Bill Gates backs $30 million push for early Alzheimer's diagnostics

Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer's disease.

J&J beats quarterly expectations on drug sales surge, shares jump

Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent.

Related Videos

Chocolate-flavoured crickets can help iron deficiency, says inventor

Researchers perfect fingerprint technique to protect pangolins

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here